Ethinylestradiol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00977 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 13 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | zinc, elevated plasma | KG + DL |
| 2 | pyogenic arthritis-pyoderma gangrenosum-acne syndrome | KG + DL |
| 3 | demodicidosis of sebaceous gland | KG + DL |
| 4 | sebaceous gland anomaly | KG + DL |
| 5 | amenorrhea (disease) | KG + DL |
| 6 | duodenal ulcer (disease) | KG + DL |
| 7 | hypoalphalipoproteinemia | KG + DL |
| 8 | duodenogastric reflux | KG + DL |
| 9 | familial acanthosis nigricans | KG + DL |
| 10 | isolated congenital adermatoglyphia | KG + DL |
| 11 | urticaria, familial localized heat | KG + DL |
| 12 | familial pityriasis rubra pilaris | KG + DL |
| 13 | Beare-Stevenson cutis gyrata syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.